Abstract The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a
World Health Organization workshop in 1999. The initial goals were (1) to propose a new …

The selection of pharmacotherapy for patients with allergic rhinitis (AR) depends on several
factors, including age, prominent symptoms, symptom severity, control of AR, patient …

This is an updated guideline for the diagnosis and management of allergic and non‐allergic
rhinitis, first published in 2007. It was produced by the Standards of Care Committee of the …

Rhinitis is an umbrella term that encompasses many different subtypes, several of which still
elude complete characterization. The concept of phenotyping, being the definition of disease …

This report has been prepared by the European Academy of Allergy and Clinical
Immunology Task Force on Allergic Rhinitis (AR) comorbidities. The aim of this …

Background Allergic rhinitis induced by house dust mites (HDMs) is a highly prevalent but
often underdiagnosed and undertreated/untreated chronic disease. It often has a negative …

Allergic rhinitis (AR) poses a global health problem and can be challenging to treat. Many of
the current symptomatic treatments for AR have been available for decades, yet there has …

Combined allergic rhinitis and asthma syndrome (CARAS) is a concept of “one airway–one
disease” or “unified airway disease “. The upper and lower airway inflammation …

Objective: Bilastine is a potent and highly selective H1-antihistamine approved for the
treatment of allergic rhinoconjunctivitis and urticaria. This article summarizes available data …

Abstract Background General practitioners (GPs), community pharmacists and allergic
rhinitis (AR) patients in Italy were surveyed in order to gain insight from all three …